Sprinter and marathoner CAR T cells reveal their distinct cancer-killing behavior
The study lays a foundation for designing CAR molecules that maximize antitumor activity beyond B cell malignancies.
Read More
solid tumors
From bench to bedside and back: CAR T cells armed with IL-15 show promise in treating solid cancers
Researchers relate their journey to finding a promising method to address CAR T cell challenges in treating solid tumors.
Read More
CAR NKT cells, a promising step forward in the treatment of solid tumors
An ongoing clinical trial shows that human CAR NKT cells are safe and, in 1 of 3 patients, induced regression of metastatic lesions.
Read More
Special delivery of IL-7 signaling makes all the difference for CAR T cells fighting solid tumors
Since he was in college, Thomas Shum wanted to pursue a career in cancer research. As he advanced in his studies, he was able to
Read More